Asia-Pacific MAb Biosimilars Market Report 2017

August 2017 | 119 pages | ID: A4F81F90CF4EN
QYResearch

Abstracts

In this report, the Asia-Pacific MAb Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of MAb Biosimilars for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific MAb Biosimilars market competition by top manufacturers/players, with MAb Biosimilars sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Biocon
• Celltrion
• Dr. Reddy's Laboratories
• Hospira
• 3SBio
• Accord Healthcare
• AET Biotech
• Allergan
• Alvartis Pharma
• Amega Biotech
• Amgen
• Apotex
• BioXpress Therapeutics
• Natco Pharma
• Sanifo
• Synthon

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Synthetic chemicls
• Biopharmaceuticals
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of MAb Biosimilars for each application, includin

• Chronic and autoimmune diseases
• Oncology

Contents

Asia-Pacific MAb Biosimilars Market Report 2017

1 MAB BIOSIMILARS OVERVIEW

1.1 Product Overview and Scope of MAb Biosimilars
1.2 Classification of MAb Biosimilars by Product Category
  1.2.1 Asia-Pacific MAb Biosimilars Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific MAb Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Synthetic chemicls
  1.2.4 Biopharmaceuticals
  1.2.5 Others
1.3 Asia-Pacific MAb Biosimilars Market by Application/End Users
  1.3.1 Asia-Pacific MAb Biosimilars Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Chronic and autoimmune diseases
  1.3.3 Oncology
1.4 Asia-Pacific MAb Biosimilars Market by Region
  1.4.1 Asia-Pacific MAb Biosimilars Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of MAb Biosimilars (2012-2022)
  1.5.1 Asia-Pacific MAb Biosimilars Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific MAb Biosimilars Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC MAB BIOSIMILARS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific MAb Biosimilars Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific MAb Biosimilars Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific MAb Biosimilars Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific MAb Biosimilars (Volume and Value) by Type
  2.2.1 Asia-Pacific MAb Biosimilars Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific MAb Biosimilars Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific MAb Biosimilars (Volume) by Application
2.4 Asia-Pacific MAb Biosimilars (Volume and Value) by Region
  2.4.1 Asia-Pacific MAb Biosimilars Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific MAb Biosimilars Revenue and Market Share by Region (2012-2017)

3 CHINA MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

3.1 China MAb Biosimilars Sales and Value (2012-2017)
  3.1.1 China MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  3.1.2 China MAb Biosimilars Revenue and Growth Rate (2012-2017)
  3.1.3 China MAb Biosimilars Sales Price Trend (2012-2017)
3.2 China MAb Biosimilars Sales Volume and Market Share by Type
3.3 China MAb Biosimilars Sales Volume and Market Share by Application

4 JAPAN MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan MAb Biosimilars Sales and Value (2012-2017)
  4.1.1 Japan MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan MAb Biosimilars Revenue and Growth Rate (2012-2017)
  4.1.3 Japan MAb Biosimilars Sales Price Trend (2012-2017)
4.2 Japan MAb Biosimilars Sales Volume and Market Share by Type
4.3 Japan MAb Biosimilars Sales Volume and Market Share by Application

5 SOUTH KOREA MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea MAb Biosimilars Sales and Value (2012-2017)
  5.1.1 South Korea MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea MAb Biosimilars Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea MAb Biosimilars Sales Price Trend (2012-2017)
5.2 South Korea MAb Biosimilars Sales Volume and Market Share by Type
5.3 South Korea MAb Biosimilars Sales Volume and Market Share by Application

6 TAIWAN MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan MAb Biosimilars Sales and Value (2012-2017)
  6.1.1 Taiwan MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan MAb Biosimilars Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan MAb Biosimilars Sales Price Trend (2012-2017)
6.2 Taiwan MAb Biosimilars Sales Volume and Market Share by Type
6.3 Taiwan MAb Biosimilars Sales Volume and Market Share by Application

7 INDIA MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

7.1 India MAb Biosimilars Sales and Value (2012-2017)
  7.1.1 India MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  7.1.2 India MAb Biosimilars Revenue and Growth Rate (2012-2017)
  7.1.3 India MAb Biosimilars Sales Price Trend (2012-2017)
7.2 India MAb Biosimilars Sales Volume and Market Share by Type
7.3 India MAb Biosimilars Sales Volume and Market Share by Application

8 SOUTHEAST ASIA MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia MAb Biosimilars Sales and Value (2012-2017)
  8.1.1 Southeast Asia MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia MAb Biosimilars Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia MAb Biosimilars Sales Price Trend (2012-2017)
8.2 Southeast Asia MAb Biosimilars Sales Volume and Market Share by Type
8.3 Southeast Asia MAb Biosimilars Sales Volume and Market Share by Application

9 AUSTRALIA MAB BIOSIMILARS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia MAb Biosimilars Sales and Value (2012-2017)
  9.1.1 Australia MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia MAb Biosimilars Revenue and Growth Rate (2012-2017)
  9.1.3 Australia MAb Biosimilars Sales Price Trend (2012-2017)
9.2 Australia MAb Biosimilars Sales Volume and Market Share by Type
9.3 Australia MAb Biosimilars Sales Volume and Market Share by Application

10 ASIA-PACIFIC MAB BIOSIMILARS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Biocon
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 MAb Biosimilars Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Biocon MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Celltrion
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 MAb Biosimilars Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Celltrion MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Dr. Reddy's Laboratories
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 MAb Biosimilars Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Dr. Reddy's Laboratories MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Hospira
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 MAb Biosimilars Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Hospira MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 3SBio
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 MAb Biosimilars Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 3SBio MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Accord Healthcare
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 MAb Biosimilars Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Accord Healthcare MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 AET Biotech
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 MAb Biosimilars Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 AET Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Allergan
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 MAb Biosimilars Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Allergan MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Alvartis Pharma
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 MAb Biosimilars Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Alvartis Pharma MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Amega Biotech
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 MAb Biosimilars Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Amega Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Amgen
10.12 Apotex
10.13 BioXpress Therapeutics
10.14 Natco Pharma
10.15 Sanifo
10.16 Synthon

11 MAB BIOSIMILARS MANUFACTURING COST ANALYSIS

11.1 MAb Biosimilars Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of MAb Biosimilars

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 MAb Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of MAb Biosimilars Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC MAB BIOSIMILARS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific MAb Biosimilars Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific MAb Biosimilars Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific MAb Biosimilars Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific MAb Biosimilars Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific MAb Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific MAb Biosimilars Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific MAb Biosimilars Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific MAb Biosimilars Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific MAb Biosimilars Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific MAb Biosimilars Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific MAb Biosimilars Price Forecast by Type (2017-2022)
15.4 Asia-Pacific MAb Biosimilars Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of MAb Biosimilars
Figure Asia-Pacific MAb Biosimilars Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific MAb Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic chemicls Product Picture
Figure Biopharmaceuticals Product Picture
Figure Others Product Picture
Figure Asia-Pacific MAb Biosimilars Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of MAb Biosimilars by Application in 2016
Figure Chronic and autoimmune diseases Examples
Figure Oncology Examples
Figure Asia-Pacific MAb Biosimilars Market Size (Million USD) by Region (2012-2022)
Figure China MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure India MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific MAb Biosimilars Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific MAb Biosimilars Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific MAb Biosimilars Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific MAb Biosimilars Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific MAb Biosimilars Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific MAb Biosimilars Sales Share by Players/Suppliers
Figure Asia-Pacific MAb Biosimilars Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific MAb Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific MAb Biosimilars Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific MAb Biosimilars Revenue Share by Players
Figure 2017 Asia-Pacific MAb Biosimilars Revenue Share by Players
Table Asia-Pacific MAb Biosimilars Sales and Market Share by Type (2012-2017)
Table Asia-Pacific MAb Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of MAb Biosimilars by Type (2012-2017)
Figure Asia-Pacific MAb Biosimilars Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific MAb Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific MAb Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of MAb Biosimilars by Type (2012-2017)
Figure Asia-Pacific MAb Biosimilars Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific MAb Biosimilars Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific MAb Biosimilars Sales Share by Region (2012-2017)
Figure Sales Market Share of MAb Biosimilars by Region (2012-2017)
Figure Asia-Pacific MAb Biosimilars Sales Market Share by Region in 2016
Table Asia-Pacific MAb Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific MAb Biosimilars Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of MAb Biosimilars by Region (2012-2017)
Figure Asia-Pacific MAb Biosimilars Revenue Market Share by Region in 2016
Table Asia-Pacific MAb Biosimilars Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific MAb Biosimilars Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific MAb Biosimilars Sales Market Share by Application (2012-2017)
Figure Asia-Pacific MAb Biosimilars Sales Market Share by Application (2012-2017)
Figure China MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure China MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure China MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table China MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table China MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure China MAb Biosimilars Sales Volume Market Share by Type in 2016
Table China MAb Biosimilars Sales Volume (K Units) by Applications (2012-2017)
Table China MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure China MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure Japan MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Japan MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table Japan MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table Japan MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Japan MAb Biosimilars Sales Volume Market Share by Type in 2016
Table Japan MAb Biosimilars Sales Volume (K Units) by Applications (2012-2017)
Table Japan MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Japan MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure South Korea MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table South Korea MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure South Korea MAb Biosimilars Sales Volume Market Share by Type in 2016
Table South Korea MAb Biosimilars Sales Volume (K Units) by Applications (2012-2017)
Table South Korea MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure South Korea MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure Taiwan MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table Taiwan MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Taiwan MAb Biosimilars Sales Volume Market Share by Type in 2016
Table Taiwan MAb Biosimilars Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Taiwan MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure India MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure India MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure India MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table India MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table India MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure India MAb Biosimilars Sales Volume Market Share by Type in 2016
Table India MAb Biosimilars Sales Volume (K Units) by Application (2012-2017)
Table India MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure India MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure Southeast Asia MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia MAb Biosimilars Sales Volume Market Share by Type in 2016
Table Southeast Asia MAb Biosimilars Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia MAb Biosimilars Sales Volume Market Share by Application in 2016
Figure Australia MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Australia MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia MAb Biosimilars Sales Price (USD/Unit) Trend (2012-2017)
Table Australia MAb Biosimilars Sales Volume (K Units) by Type (2012-2017)
Table Australia MAb Biosimilars Sales Volume Market Share by Type (2012-2017)
Figure Australia MAb Biosimilars Sales Volume Market Share by Type in 2016
Table Australia MAb Biosimilars Sales Volume (K Units) by Applications (2012-2017)
Table Australia MAb Biosimilars Sales Volume Market Share by Application (2012-2017)
Figure Australia MAb Biosimilars Sales Volume Market Share by Application in 2016
Table Biocon MAb Biosimilars Basic Information List
Table Biocon MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocon MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Biocon MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Biocon MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Celltrion MAb Biosimilars Basic Information List
Table Celltrion MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celltrion MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Celltrion MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Celltrion MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Dr. Reddy's Laboratories MAb Biosimilars Basic Information List
Table Dr. Reddy's Laboratories MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Hospira MAb Biosimilars Basic Information List
Table Hospira MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hospira MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Hospira MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Hospira MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table 3SBio MAb Biosimilars Basic Information List
Table 3SBio MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure 3SBio MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure 3SBio MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure 3SBio MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Accord Healthcare MAb Biosimilars Basic Information List
Table Accord Healthcare MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Accord Healthcare MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Accord Healthcare MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Accord Healthcare MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table AET Biotech MAb Biosimilars Basic Information List
Table AET Biotech MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AET Biotech MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure AET Biotech MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure AET Biotech MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Allergan MAb Biosimilars Basic Information List
Table Allergan MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Allergan MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Allergan MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Alvartis Pharma MAb Biosimilars Basic Information List
Table Alvartis Pharma MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Amega Biotech MAb Biosimilars Basic Information List
Table Amega Biotech MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amega Biotech MAb Biosimilars Sales (K Units) and Growth Rate (2012-2017)
Figure Amega Biotech MAb Biosimilars Sales Market Share in Asia-Pacific (2012-2017)
Figure Amega Biotech MAb Biosimilars Revenue Market Share in Asia-Pacific (2012-2017)
Table Amgen MAb Biosimilars Basic Information List
Table Apotex MAb Biosimilars Basic Information List
Table BioXpress Therapeutics MAb Biosimilars Basic Information List
Table Natco Pharma MAb Biosimilars Basic Information List
Table Sanifo MAb Biosimilars Basic Information List
Table Synthon MAb Biosimilars Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of MAb Biosimilars
Figure Manufacturing Process Analysis of MAb Biosimilars
Figure MAb Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of MAb Biosimilars Major Manufacturers in 2016
Table Major Buyers of MAb Biosimilars
Table Distributors/Traders List
Figure Asia-Pacific MAb Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific MAb Biosimilars Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific MAb Biosimilars Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific MAb Biosimilars Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific MAb Biosimilars Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific MAb Biosimilars Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific MAb Biosimilars Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific MAb Biosimilars Revenue Market Share Forecast by Region in 2022
Figure China MAb Biosimilars Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan MAb Biosimilars Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea MAb Biosimilars Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan MAb Biosimilars Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India MAb Biosimilars Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia MAb Biosimilars Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia MAb Biosimilars Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific MAb Biosimilars Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific MAb Biosimilars Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific MAb Biosimilars Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific MAb Biosimilars Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific MAb Biosimilars Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific MAb Biosimilars Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific MAb Biosimilars Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources